Metformin reduces circulating factor VIi concentrations in patients with type 2 diabetes mellitus
Grant, P.J.
Thrombosis and Haemostasis 80(1): 209-210
1998
ISSN/ISBN: 0340-6245 PMID: 9684819 Document Number: 486136
Document emailed within 1 workday
Related Documents
Ballary, C.; Desai, A. 2003: Efficacy and safety of a combination of metformin and rosiglitaone in patients with type 2 diabetes mellitus--a postmarketing study Journal of the Indian Medical Association 101(2): 113-114; 123Cherulil, S.J.; Chafekar, N.D.; Babaliche, P. 2020: Prevalence of Vitamin B12 Defi ciency and Clinical Neuropathy with Metformin use in Type 2 Diabetes Mellitus Patients Journal of the Association of Physicians of India 68(1): 47
Pongchaidecha, M.; Srikusalanukul, V.; Chattananon, A.; Tanjariyaporn, S. 2004: Effect of metformin on plasma homocysteine, vitamin B12 and folic acid: a cross-sectional study in patients with type 2 diabetes mellitus Journal of the Medical Association of Thailand 87(7): 780-787
González-Ortiz, M.; Martínez-Abundis, E. 2004: Efficacy and safety of glimepiride plus metformin in a single presentation, as combined therapy, in patients with type 2 diabetes mellitus and secondary failure to glibenclamide, as monotherapy Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 56(3): 327-333
Zhang, J.-p.; Yang, W.-y.; Hong, T.-p.; Yang, J.-k.; Xiao, W.-h.; Gao, H.-w.; Yang, Y. 2007: Efficacy and safety of extended-release metformin in treatment of type 2 diabetes mellitus Zhonghua Yi Xue Za Zhi 87(18): 1238-1240
Song, H.P.; Han, X.Y.; He, Y.; Kang, T.B.; Wu, H.W. 1991: Activities of aldose reductase, ATPases, and nucleotide concentrations of erythrocytes in patients with type 2 (non-insulin-dependent) diabetes mellitus Chinese Medical Journal 104(10): 818-824
Ribera, L.; González-Clemente, Jé.Miguel.; López Alba, T.; Almirall, J. 2002: Fatal lactic acidosis due to metformin in a male with type 2 diabetes mellitus and dehydration. Comments about a patient information leaflet Medicina clinica 119(4): 158
Katavetin, P.; Eiam-Ong, S.; Suwanwalaikorn, S. 2006: Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy Journal of the Medical Association of Thailand 89(2): 170-177
Oshodi, T.; Ebuehi, O.A.T.; Ojewunmi, O.; Udenze, I.; Soriyan, T. 2012: Circulating adipokine levels in type 2 diabetes mellitus in Lagos, Nigeria Nigerian Quarterly Journal of Hospital Medicine 22(1): 25-28
Ermakova, N.A.; Syrodeeva, O.N.; Antsiferov, M.B.; Balatskaia, N.V.; Krasnova, L.B. 2008: Role of vascular endothelial growth factor in the development of diabetic retinopathy in patients with type 1 diabetes mellitus Vestnik Oftalmologii 124(1): 25-28
Al-Masri, A.A.; El Eter, E.; Tayel, S.; Zamil, H. 2014: Differential associations of circulating peroxiredoxins levels with indicators of glycemic control in type 2 diabetes mellitus European Review for Medical and Pharmacological Sciences 18(5): 710-716
Moin, T. 2019: Should Adults with Prediabetes Be Prescribed Metformin to Prevent Diabetes Mellitus? Yes: High-Quality Evidence Supports Metformin Use in Persons at High Risk American Family Physician 100(3): 134-135
Zak, K.P.; Popova, V.V.; Mel'nichenko, S.V.; Tron'ko, E.N.; Man'kovskiĭ, B.N. 2010: The level of circulating cytokines and chemokines in the preclinical and early clinical stages of type IA diabetes mellitus development Terapevticheskii Arkhiv 82(10): 10-15
Kirk, J.K.; Pearce, K.A.; Michielutte, R.; Summerson, J.H. 1999: Troglitazone or metformin in combination with sulfonylureas for patients with type 2 diabetes? Journal of Family Practice 48(11): 879-882
Lavrenko, A.V.; Kutsenko, L.A.; Solokhina, I.L.; Rasin, M.S.; Kaĭdashev, I.P. 2011: Efficacy of metformin as initial therapy in patients with coronary artery disease and diabetes type 2 Likars'ka Sprava 2011(1-2): 89-95
Heljić, B.ći.; Cengić, M.; Dilić, M. 2002: Obesity as a risk factor for the onset of type 2 diabetes mellitus Medicinski Arhiv 56(1): 35-37
Parry-Strong, A.; Langdana, F.; Haeusler, S.; Weatherall, M.; Krebs, J. 2016: Sublingual vitamin B12 compared to intramuscular injection in patients with type 2 diabetes treated with metformin: a randomised trial New Zealand Medical Journal 129(1436): 67-75
Farrell, C.; Moran, J. 2014: Comparison of comorbidities in patients with pre-diabetes to those with diabetes mellitus type 2 Irish Medical Journal 107(3): 72-74
Ezenwaka, C.E.; Offiah, N.V.; Davis, G. 2000: Early metabolic defects for developing diabetes mellitus among offspring of patients with type 2 diabetes are independent of gender West Indian Medical Journal 49(4): 276-280
Schiel, R.; Bocklitz, G.; Braun, A.; Leppert, K.; Stein, G.; Müller, U.A. 2003: Cognitive function and quality of diabetes care in patients with Type-2-diabetes mellitus in general practitioner practice European Journal of Medical Research 8(9): 419-427